Friday, July 29, 2016

The indiana had more pharmacy robberies

Despite some targeted measures to protect pharmacies, Indiana isn't shedding its unwanted designation as the No. 1 state for pharmacy robberies.

Consider this statistic: Indiana had more pharmacy robberies from the beginning of 2013 to May of this year than any other state.

Indiana logged 367 robberies, while California — with a population about six times larger — came in second with 310 robberies in the same time period. In 2015, 175 robberies occurred, 132 in Marion County alone, more than the entire state of California for the previous year, said Donna Wall, president of the Indiana Board of Pharmacy.

On Tuesday, the members of the Governor’s Task Force on Drug Enforcement, Treatment, and Prevention mulled these troubling statistics and more as they heard from Wall and others fighting on the front lines to improve the situation.

Randy Hitchens, executive vice president of the Indiana Pharmacists Alliance, said he frequently fields calls from concerned pharmacists. Hitchens has little solace to offer.“We feel a little weak,” Hitchens said. “We scratch our heads about what we can do.”

Nor is it just traditional robberies in pharmacies. Every time the pharmacy board meets, members have to revoke the license of one or two pharmacy techs because they were diverting pills, Wall said.

But the bulk of the threat does not come from the inside.

Last year, 17 Marion County pharmacies were robbed three times, three pharmacies were robbed four times, and four pharmacies were robbed five times.

"Last year was just a horrible, horrible year," Indianapolis Metropolitan Police Department Lt. Craig McCart told the drug task force.

Many stores — especially those in Marion County — have taken steps to improve security, adding armed guards and time release safes to house the most desired medications, mostly opioids such as oxycodone.

Still, there have been 64 pharmacy robberies since the start of the year in Indiana. IMPD considers the fact that it has seen “only” 43 pharmacy robberies since January a relative success.

"It’s still a huge problem, but we really are looking at it as a bit of a victory because we are so far below where we were last year,” McCart said.Just because Indianapolis has made a dent in the problem does not mean the situation has been resolved, Wall and McCart agreed.

“As security measures in Marion County are ramping up, they’re going out to other places,” Wall said.

Whenever police in Louisville, Ky., Cincinnati, Kokomo, Danville or Muncie identify a pharmacy robbery suspect in their jurisdictions, the person almost always hails from Indianapolis, McCart said.

The people behind the robberies have a well-developed system, he said. Rarely do they use what they steal. Often they enlist juveniles, many with no criminal record, offering them $1,000 to $2,000 per job. The juveniles don’t stand to do much jail time even if they get caught.

In some cases, the juveniles take the pills and run out to an older guy, waiting in a car in a parking lot, McCart said. The criminals have become so savvy that in many instances, they have the juvenile give them the stolen pills but keep the bottles in case they are equipped with GPS trackers.

“They’re fairly sophisticated,” McCart said. “Right now, we’re having some degree of success. But it’s still obviously a huge problem.”

The problem has extended to pharmacies statewide, Wall said. Of the seven people on the pharmacy board, one pharmacist, who has his own store, has had a break-in in the past month. Another, who works in a chain, has had two attempted robberies in the past four months.

“This is the type of problem we’re dealing with, and this is why the pharmacy board is really anxious, and anyone in pharmacy is really anxious, about what’s going on here,” Wall said. “So far, we have been really blessed that no one has been injured. … But it’s really scary.”Just because Indianapolis has made a dent in the problem does not mean the situation has been resolved, Wall and McCart agreed.

“As security measures in Marion County are ramping up, they’re going out to other places,” Wall said.

Whenever police in Louisville, Ky., Cincinnati, Kokomo, Danville or Muncie identify a pharmacy robbery suspect in their jurisdictions, the person almost always hails from Indianapolis, McCart said.

The people behind the robberies have a well-developed system, he said. Rarely do they use what they steal. Often they enlist juveniles, many with no criminal record, offering them $1,000 to $2,000 per job. The juveniles don’t stand to do much jail time even if they get caught.

In some cases, the juveniles take the pills and run out to an older guy, waiting in a car in a parking lot, McCart said. The criminals have become so savvy that in many instances, they have the juvenile give them the stolen pills but keep the bottles in case they are equipped with GPS trackers.

“They’re fairly sophisticated,” McCart said. “Right now, we’re having some degree of success. But it’s still obviously a huge problem.”

The problem has extended to pharmacies statewide, Wall said. Of the seven people on the pharmacy board, one pharmacist, who has his own store, has had a break-in in the past month. Another, who works in a chain, has had two attempted robberies in the past four months.

“This is the type of problem we’re dealing with, and this is why the pharmacy board is really anxious, and anyone in pharmacy is really anxious, about what’s going on here,” Wall said. “So far, we have been really blessed that no one has been injured. … But it’s really scary.”

http://www.indystar.com/story/news/2016/07/27/indiana-continues-lead-us-pharmacy-robberies/87596430/

The Centre will consider plans to ease pains of e-pharmacy business


The Centre will consider next week a proposal for drawing up separate guidelines for the sale of medicines online to help establish a legal framework for e-pharmacy businesses.

The matter was taken up at the Centre’s first interaction with start-up founders on Thursday, Commerce and Industry Minister Nirmala Sitharaman said. She said e-pharmacy-related issues will also be discussed in the Parliament.
Amend law

At a recent event, K. B. Aggarwal, Additional Secretary (Food and Drugs), Ministry of Health and Family Welfare, had said: “With the advent of e-pharmacy, there is a need to amend the Drugs and Cosmetics Act, 1940, as it does not differentiate between offline and online pharmacies.”

Dhaval Shah, founder of the online pharma start-up PharmEasy – a platform connecting people to their local pharmacy or registered vendor for the services they opt for – said that e-pharmacy businesses want the government to soon bring out separate guidelines to ensure ease of doing business for the sector. Mr. Shah, who attended the Thursday’s meeting, said though some offline pharmacies might consider orders without prescriptions, PharmEasy ensures that pharmacies in its network reject orders without prescriptions, and that its entire operation is done only on the basis of a valid prescription.

“We want to improve the medical sector environment.”

The meeting with start-up founders was convened by the Department of Industrial Policy and Promotion (DIPP) – the nodal government body on the start-up initiative. However, only 28 start-ups, including majors such as Practo and Mapmygenome, participated. They raised issues related to taxation, complex compliance requirements and other difficulties in doing business in India. An official statement on the participants showed that leading start-ups such as Paytm was represented in the two-hour-long meeting not by their founders, but only senior executives.
Poor participation

Ms. Sitharaman said the government “was keen to know their (founders’) views on the start-up activity, their expectation from the government and the difficulties they are facing with respect to various other ministries.”

http://www.thehindu.com/business/Industry/centre-plans-to-ease-pains-of-epharmacy-business/article8912434.ece

Wednesday, July 27, 2016

Pharmacy will have to evolve as technologies are introduced and the Society of Hospital Pharmacists of Australia

Michaels was addressing the two day Future Summit, now being held in Melbourne.

Michaels says one of the most important issues being addressed is planning for an increasingly digitised healthcare system.

“We expect the role of the pharmacy workforce to evolve and this will accelerate with the introduction of electronic medication management systems and electronic medical records,” she says.

“These technological changes will have the attention of federal and state governments because of the potential impact on health budgets and because they will be keen to maximise advances in health outcomes.

“New electronic systems could pave the way for pharmacists and pharmacy technicians to have more time for bedside consultations, with other health professionals, and to ensure the best decisions are made about patient medication.”

Michaels says that SHPA is planning ahead to ensure the pharmacy workforce can take full advantage of likely changes to a digital healthcare system. This means ensuring SHPA provides the best support and continuing professional development, she says,

“One stream of Summit activity has been focused on the development of a tool kit for writing business cases. It will be used by pharmacists to support creation of new pharmacy services by undertaking analysis and presenting well-structured business cases to support their proposals.

“When pharmacists working in hospitals are keen to foster new initiatives to deliver better medications management, they are competing for limited funds against robust competition.

“Development of a well-considered, rigorous business case is an essential part of gaining appropriate funding in a competitive environment,” Michaels says.

“We are giving hospital pharmacists the tools and insights they need to design and follow through on medicines related initiatives that will elevate the quality and safety of health care in Australia’s hospitals.

“The Summit is also developing a mentoring program for pharmacists who are preparing for transition into more senior roles where they will require significant non-clinical skills.

“These skills could include leadership, management, communication, research and education,”  Michaels says.

“Participation in the Future Summit is very competitive and brings together pharmacy’s most important leaders and thought champions from around Australia. Participants are chosen via a rigorous selection process and they are working together to build robust foundations for future change.”

https://ajp.com.au/news/pharmacy-workforce-evolve/

The need to amend the Drugs and Cosmetics Act, 1940 to promote e-pharmacy in India

With the advent of e-pharmacy, there is a need to amend the Drugs and Cosmetics Act, 1940 as it does not differentiate between offline and online pharmacies. The government is seized of the issue and is working towards amending the existing law to develop a framework where the consumers are benefited, said K. B. Aggarwal, Additional Secretary (Food and Drugs), Ministry of Health & Family Welfare. He was launching a report at a session on 'E-pharmacy in India - Last Mile Access of Medicines' organised by FICCI.

Aggarwal said that e-pharmacy would allow easy availability of drugs at all hours. However, there were concerns with respect to legitimacy of e-pharmacies, patients safety and privacy, misuse of e-pharmacy and adverse effect on retailers business.

He said that there was a need to create e-pharmacy guidelines which allow proper tracking and monitoring of sales of drugs, authenticity of online pharmacists and prescriptions, details of patients, thereby helping in reducing drug abuse and counterfeiting. He added that linking a person's Aadhar number with e-pharmacy would ensure correctness of person seeking medicines.

Aggarwal said that for ensuring privacy and confidentiality of information, deliberations were taking place and soon the suggestions will be put up for further discussions among the stakeholders. He added that the DCGI was working towards developing its online platform and the system should be stable by the end of December 2016.

Dr. S. Eswara Reddy, Joint Drugs Controller, Central Drugs Standard Control Organization, said that the government was working towards drafting a new Drugs & Cosmetics Act, 2016 to meet the current regulatory requirements related to safety, efficacy and quality of drugs. For the government, pharmaceuticals was a priority sector, therefore it was critical to ensure that its regulations are strengthened. He added that there should be a standard format of prescriptions.

In his presentation Jayant Singh, Director, Frost & Sullivan, said that e-pharmacy was one of the technology advancements that is about to create a huge demand in the upcoming days. There was a huge demand for access models that help patients and consumers avail the convenience of medicine delivery without having to leave their homes. With the use of technology and access to inventory of multiple stores at a time, e-pharmacies can aggregate supplies, making otherwise-hard-to-find medicines available to consumers across the country.

Dr. Manisha Shridhar, Regional Adviser, World Health Organization, said that for sale of online drugs, in the EU legitimate online pharmacies will have to carry a logo and India could learn from their processes and create its own logo for e-pharmacy. She added that there was a need to work on Direct to Consumer (DTC) as with emergence of e-pharmacy many issues will emerge that would need to be deliberated upon.

In his presentation on the consumer survey, Afaq Hussain, Director, BRIEF Market Research, said that 90 per cent of the respondents were willing to buy medicines online as e-pharmacy brings with the convenience of ordering from mobile applications; all required medicines are available at one store/website; home delivery of medicines; better quality of medicines; better pricing and e-bill for tacking and reimbursement.

In his special address,  Arvind Gupta, Founder & Head, Digital India Foundation, said that there was a need to look at e-pharmacy sector in a comprehensive manner keeping in view the entire healthcare chain. He added that the Aadhar number should be integrated when a person seeks drugs from e-pharmacy to monitor drug abuse and its misuse. He added that there was a need to standardize labs to create digi lockers where the patients' records are safely documented for reference by doctors.

Prashant Tandon, Founder & CEO, 1MG, Core Member, FICCI E-Commerce Committee, said that digital tracking and monitoring will take Digital India forward. The Drugs and Cosmetics Act does not address many concerns, hence incremental steps were required to ensure access to quality medicines at affordable price. He added that e-pharmacy sector needs guidelines to function smoothly.

Dr. A Didar Singh, Secretary General, FICCI, said that there was an urgent need to nurture the e-pharmacy sector with the right set of policy frameworks and guidelines in order to provide the benefits that the sector fosters for the consumers. As one of the key agenda of the Government has been to provide easy, quality and affordable access of health services to the consumers, the evolving concept of e-pharmacy will definitely give an impetus to the health sector of the country.

http://www.pharmabiz.com/NewsDetails.aspx?aid=96491&sid=2

Sunday, July 24, 2016

HIV activists from around the Indian over crackdown on non-governmental organisations (NGOs)


 Worried about the shrinking space for civil society organisations in India, HIV activists from around the world protested outside the Indian embassy in Durban, South Africa. Humanitarian aid organisations have expressed concern over Prime Minister Narendra Modi’s crackdown on non-governmental organisations (NGOs), particularly Lawyers Collective, stating that it will have a direct impact on India’s HIV response.

In a press statement, activists said “this condemnation needs to be seen in the context of the ongoing U.N. General Assembly Special Session on AIDS in New York. While on the one hand member States of the U.N. [including India] are pledging support to end AIDS by 2030, organisations such as Lawyers Collective in India, who have stood for the rights of those most affected by HIV, are being baselessly harassed, victimised and silenced.” The activists handed over a petition to the consulate, which has been signed by organisations are attending the international public health event.
Curb on donations

In June, the government suspended the legal aid organisation’s registration under the Foreign Contribution Regulation Act (FCRA) for 6 months, meaning it could no longer receive any donations from abroad. The Lawyer’s Collective has been instrumental in drafting the HIV/AIDS Bill, 2014 — a landmark anti-discrimination legislation.

“We are extremely concerned about the situation in India. The government understand how important civil society is, and has been, to the global AIDS response. It was basis for achieving political commitment, driving treatment rollout. India needs it’s civil society more than ever because as of now 2.3 million are HIV positive but only 1 million people on treatment. Organisations like the Lawyers Collective have been at the forefront of activism,” said Mark Heywood, Executive Director of SECTION27, a law centre promoting human rights.

“We have not been able to work and our work in HIV is being impeded. We have taken up certain cases, which are not to the liking of present government. Irrespective of funding problems, we will continue our work,” said Anand Grover, founder member of the Lawyers Collective.

Besides the clampdown on NGOs, another significant concern voiced by the international community was the change in India’s policy towards Intellectual Property Rights (IPR).

“India is the pharmacy of the world and remains vital to nearly 70 million on treatment. Another 20 million people will be on treatment in the next 5 years… If India changes its stand, patients across the world will suffer,” Mr. Heywood added.

http://www.thehindu.com/news/international/world/hiv-activists-voice-concern-over-crackdown-on-ngos/article8883329.ece


Medical courses in India and students 7 types of medical degrees with related jobs


Medical courses are vast in India and students have a plethora of options to choose from. MBBS, Dental Medicine, Homeopathic Medicine & Surgery, Ayurvedic Medicine and Surgery, Physiotherapy, Pharmacy, Nursing, Unani Medicine, Medical Lab technician, Occupational Therapy, that can be chosen by students after taking an entrance exam.

With an MBBS degree, students can join medical colleges, hospitals, nursing home, health corporations, health ministry, medical health society, back-office medical consultancy and pharmaceutical industries.  However, the medical field is not restricted to MBBS and its allied courses. There are several other medical diploma courses, certificate courses and Bachelor degree courses which students can apply for.

The candidates who are preparing for the medical entrance exams can take a look at the different medical degrees and job opportunities listed below:

Medical TechnologyA Bachelor's degree in medical technology helps a student to get acquainted with a variety of complex laboratory instruments used to diagnose, restrict and treat diseases.  Several different subjects related to medicine, including Microbiology, Hematology, Immunology and Serology are covered in this course and microscopic examination, blood banking, urinalysis and body fluid analysis are also discussed during the course of study. With the amount of automation being introduced in medicine, a Bachelor's degree in Medical Technology will help one secure an entry-level job as a medical technologist or medical laboratory scientist.

NursingAlready a much popular degree with female students, a Bachelor's degree in Nursing can help a student have a window seat to the high-pressure environment of the medical profession along with gaining critical thinking, communication and management skills. Students learn to provide quality nursing care to patients through extensive hands-on teaching and clinical experiences. There is a growing demand for nursing in the world through UN and assignments with similar international organisations as well.

Diagnostic Medical Sonography (DMS)A Bachelor's degree programme in DMS involves non-invasive imaging of internal organs or structures using high frequency sound waves. The study covers the procedure to acquire accurate sonographic images of the abdominal, gynecologic and cardiovascular systems. Physicians can diagnose diseases and other medical ailments from information gathered by the images.

Radiotherapy
Students are trained to use radiation equipment, software and devices for the treatment of cancer. The course has immense scope as skilled professionals in the field are limited. All cancer care hospitals require students with essential professional experiences and skills to conduct radiotherapy.

Physiotherapy
Physiotherapy maintains and restores physical strength and plays a key role in helping people to improve their quality of life. It mostly deals with recuperating from injuries or age-related disorders and highly sought-after disciplines of medicine including surgery, neurology, orthopedics, cardiothoracic, vascular surgery, pediatrics, rehabilitation and sports gynecology, obstetrics, dermatology, ENT, medicine, etc. Students are taught to decrease pain in all joints of the body and normalise movements and recover patients' optimum strength and function.

BPharm
This course deals with the study of drugs and medicines, medicinal chemistry, etc and provide students with a large number of job opportunities. This is a popular job-oriented course and after completion, students can get into Bio-Technology Industries, Research & Development and Pathological Labs etc. These students are also eligible to work as Drug Therapist, Drug Inspector, Hospital Drug Coordinator and Health Inspector.

Medical Assistance
A degree programme in medical assistance teaches you to perform medical office duties such as billing, coding and scheduling appointments. The course also teaches you to carry out basic medical procedures such as capillary puncture, electrocardiography and phlebotomy.  So, a degree in medical assisting can offer you jobs such as a medical assistant, a medical receptionist or help you to pursue a related entry-level medical occupation.

http://indiatoday.intoday.in/education/story/7-types-of-medical-degrees-jobs/1/721491.html

Wednesday, July 20, 2016

The prescription for disaster: Online medicine seller Pharm easy

A person named Damyanti Gada places an order for Folvite tablets and Evion capsules with online medicine seller, PharmEasy. The company checks the accompanying prescription: Nothing is in order. Patient details are incomplete, and the doctor who has prescribed the medicines is a homeopath.

The prescription is considered fake and the order immediately cancelled.

This is not an isolated case. HT has seen several medical prescriptions signed by veterinary surgeons, aurvedic doctors and homeopaths. In each case, the online pharmacy screened the prescriptions and rejected them – at the cost of their sales.

“It’s very disturbing to let your revenues go. The same prescription would probably go to an offline chemist and would fetch medicines easily,” complained Dharmil Sheth, co-founder of PharmEasy, an online medicines selling platform, which rejects about 45-50% of orders daily due to flawed prescriptions.

For online pharmacy start-ups that are chasing an almost $1 billion market, the struggle is to convert orders into sales. E-pharmacies, which cannot sell medicines without verifying the prescriptions, are rejecting almost 5 out of 10 prescriptions daily. According to industry body, Indian Internet Pharmacy Association (IIPA), online pharmacies lose over 40% of business every day due to prescription defects.

In several cases, customers even send pictures of the medicines they need. “Customers send us images of their tablet strips or syrup bottles or at times writing down their requirements on a piece of paper and upload it. Such orders are also rejected,” Sheth said.

It is an unequal market, he says, as they are competing with pharmacy stores. Prashant Tandon, co-founder of 1Mg, an e-pharmacy, said, “The offline pharmacy sector has completely failed to check self-medication and flow of fake prescriptions.”

To sustain the business, e-pharmacies have now started assisting customers fix appointments with doctors.

Every state Food and Drug Administration has a set of guidelines for prescriptions. For Instance: The Maharashtra FDA requires prescriptions to mention the date, doctor’s name, address, registration number, dosage and duration of medication, among other things.

The government is expected to introduce guidelines for e-pharmacies soon. The drug controller general of India, GN Singh, has told HT that the committee working on the draft for e-pharmacies ecosystem to submit the papers in the next one month.

http://www.hindustantimes.com/business-news/prescription-for-disaster-online-pharmas-struggle-for-sales/story-RPVDVydc2Xt5VkViWb2NzJ.html

The pharmacy news from around the world, including more reports of Clonidine overdoses in children

Jakarta, Indonesia:  Police have named 14 hospitals and eight midwife clinics which allegedly administered fake vaccines to children, reports The Age.

Four criminal syndicates have allegedly been producing counterfeit vaccines throughout Jakarta and Java for up to 13 years.

More than 20 people have been arrested, including three doctors.

Health officials claim the counterfeit vaccines are unlikely to have caused harmful side effects given that they only contained antibiotics and intravenous fluids.

It is not yet known how many children received the fake vaccines and are vulnerable to the diseases they were supposed to be protected from.

According to The Age only a small percentage of vaccines in Indonesia are imported and they cost far more than those locally produced.

It has also became apparent that Indonesia’s Food and Drugs Agency had been warned some time ago about the issue but little was done until a police investigation earlier this year.

“Glaxo reported the existence of the fake vaccine in 2011 to the police and BPOM [the Food and Drugs Agency] but there was no reaction,” says Dr Mohammad Adib Khumaidi, the secretary-general of the Indonesian Medical Association.

The government is offering free injections to all children who were initially vaccinated at the facilities named by police.

US:  After a pharmacist gave a boy the wrong dosage of Clonidine which his parents claim killed him, other parents have come out saying they have had similar experiences with the drug.

According to the boy’s mother, eight-year-old Jake Steinbrecher had been taking the medication for three years to help manage his hyperactivity. However he immediately had a reaction when he took his usual dose last October, and eventually died on June 8 from “an autoimmune response believed to have been triggered by the [pharmacy] error,” his family said in a press release.

When tested, the results showed that the pharmacist had mixed 1000 times the prescribed dosage, Denver7 reports: instead of taking 0.03mg of the drug, Steinbrecher ingested 30mg.

Steinbrecher’s mother told InsideEdition.com that she has been approached by parents who told her their children also (non-fatally) overdosed on compounded, liquid versions of Clonidine that had been erroneously filled with too high of a dosage.

In those incidents, one boy was given a dosage 400 times the amount prescribed, while a baby was given 600 times the prescribed amount, she says.

A third parent, Alia Skiffington, also contacted Steinbrecher to share her daughter’s experience in 2007.

Laboratory tests showed Leona, then eight years old, had taken a dose of 23 milligrams per millilitre of Clonidine, while she was supposed to take 0.025 milligrams per millilitre.

The Skiffingtons were awarded $200,000 in a settlement with the pharmacy in question, which was also reprimanded by their region’s pharmacy board. The pharmacist who filled the prescription was made to pay a fine and continuing education classes but continues to practice, according to InsideEdition.com.

When dealing with a “high alert medication” like Clonidine pharmacists should exercise extreme caution, says Dr Frank Federico, chair of the National Coordinating Council for Medication Error Reporting and Prevention in the US.

UK: Community pharmacies are bracing for budget cuts following the Brexit decision and subsequent government changes.

As new government ministers begin their work, one decision that is being keenly awaited is the possible sign-off to budget cuts for British “High Street” pharmacies, reports the BBC.

UK’s Department of Health says the changes are an opportunity to bring pharmacists’ skills closer to GP practices and care homes.

However trade bodies are reportedly fearful that thousands of pharmacies could close.

“There seems to be a policy mismatch. The government puts out adverts telling people to avoid [emergency departments] and their GP, and go to pharmacies first – and yet they’re pulling the rug out from under our feet,” one pharmacist told the BBC.

A spokesman from the National Pharmacy Association said: “The Department of Health is conducting a dangerous experiment which could see local pharmacies close. Patients would be the biggest losers.

"Alistair Burt’s successor as pharmacy minister should be given the opportunity to thoroughly review the Department of Health’s plans before any steps are taken towards implementation.”

New Delhi, India: Brick-and-mortar chemists are taking e-pharmacies to court in a bid to shut them down, according to the India Times.

The All India Organisation of Chemists and Druggists (AIOCD) will approach ten High Courts in India against the central and state drug regulators for lack of action against the “illegal” operation of online pharmacies, which they claim compromises patient safety.

In response, online pharmacies are reportedly gearing up for the fight in the hopes that it would clarify misconceptions about the processes they follow and also “expose” the public safety hazards posed by offline pharmacies.

Online pharmacies are illegal in India and the central and state drug regulators’ negligence in allowing them to run risks public health, says AIOCD general secretary Suresh Gupta.

India’s 1940 Drugs & Cosmetics Act does not allow online portals to sell medicines, says Gupta, adding that a major problem with online pharmacies is that the medicine could change in transit.

https://ajp.com.au/auspharm/world-news/world-news-wrapup-19-july-2016/

Saturday, July 16, 2016

The trade defence ties between India and the czech republic visa centre in city

Chennai: With trade and defence ties between India and the Czech Republic going strong, the Czech diplomatic mission plans to open six visa processing centres in association with VFS Global services across the country.

Inaugurating the Czech republic visa application centre in the city on Friday, Milan Hovorka, the Ambassador of the Czech Republic to India, said bilateral trade between India and the Czech Republic stood at $1.2 billion in 2015.
He said the Czech prime minister would visit India later this year and the diplomatic modalities were being worked out.


With the opening of the centre at Ethiraj Salai in Egmore, the applicants would no longer need to travel to Mumbai, New Delhi or Bengaluru to apply for a Schengen visa.Around 15 Indian companies were doing business in that country in the fields of iron and steel, automobile, IT, textiles, and pharmacy.


He said Chennai topped the list in a survey on the preferred city done among travel agents.


with travel agents on which city would be preferred to launch a visa center Chennai topped the list. A number of Czech companies and experts have worked with Heavy Engineering Corporation. Skoda Power has been a technology licensor to BHEL. The now defunct Jawa established itself strongly in Indian market for decades with its popular Yezdi model (which means "it runs!"). Even now, the Czech Republic is spontaneously associated in India with world-famous Czech brands, such as Skoda, Tatra, Bata or Zetor. Since 2001, trade exchange between these two countries has been growing substantially, as proved by the fact that their mutual trade turnover has risen tenfold the envoy said.


He said the Indian market has become one of the most important destinations for Czech companies. India's role in Czech foreign trade is steadily growing thanks to the India's strong embarkation on liberalization process as the exponential growth of Indian economy has created opportunities for EU and Czech companies. India has become the second largest Asian trade partner of the Czech Republic, Milan Hovorka said.

http://timesofindia.indiatimes.com/city/chennai/Czech-Republic-visa-centre-in-city/articleshow/53233921.cms

The first pharmacy chain in India to adopt cashless payments in the using MobiKwik 98.4

98.4, a leading chain of retail pharmacy stores run by Global Healthline, has announced its collaborations with MobiKwik, India’s largest digital payments company to allow its user to facilitate cashless payments across its stores. This is the first time that a mobile wallet is being integrated across a chain of retail pharmacies.

“In the rapidly evolving digital age, mobile wallets are empowering consumers with convenient, speedy, safe and reliable cashless payment solution. 98.4 and Mobikwik collaboration supports our commitment towards enhanced customer experience.” said Mr. Sachin Mirza, Head – Marketing and Business Development, Global Healthline.  “We look forward to welcome and extend our personalised pharmacy care services to over 30 million Mobikwik users in India.” Mr. Mirza added.

Speaking on the announcement, Mrinal Sinha, COO, MobiKwik said, “as a first step to taking the MobiKwik offering to the medical industry, we have partnered with 98.4.

We hope that the end users will benefit hugely with quick processing of payments across 98.4°® pharmacy stores.”

http://www.financialexpress.com/industry/companies/using-mobikwik-98-4-becomes-first-pharmacy-chain-india-adopt-cashless-payments/317613/

Wednesday, July 13, 2016

The Narcotics Control Bureau (NCB) e-commerce increase in online pharmacies in India





New Delhi: Growing e-commerce in India is facilitating significant increase in online pharmacies, leading to easy availability of pharmaceutical drugs and their abuse, the Narcotics Control Bureau (NCB) said.

In its annual report for 2015, published on Friday, the NCB says abuse of pharmaceutical drugs in India has assumed serious proportions in recent times and the problem seems to be more serious in the northeast and northwest region of the country.

"The emergence of illegal websites (Internet Pharmacy) established in the USA, Europe etc. offering unregulated trade in a range of prescription medicines over the Internet has taken firm root in India as a supplier," said the intelligence agency.

"These online pharmacies transmit orders from paying customers to agents in India, who then procure the medicines from either legitimate or illegitimate sources before dispatching them to customers by mail and courier," NCB report added.

The sheer volume of international post makes it impossible to screen every parcel and hence a vast majority of illegal consignments passes by undetected by the authorities.

"Internet pharmacies are usually highly vulnerable and keep the identity of organisers tightly veiled. In India, nevertheless, the NCB either on its own or in coordination with the outside agencies has been making at least one bust every year over the ears," it added.

The pharmaceutical products that are abused include buprenorphine, codeine-based cough syrups, alprazolam, diazepam and other sedatives. Many of these pharmaceutical drugs are easily available over the counter and this has become the major factor that encourages their misuse, the NCB said.

There is also the perception that these pharmaceutical drugs are less harmful than hard drugs like heroin, cocaine etc.

"However, this is a misconception, since these can be addictive and also have a debilitating effect on health. Pharmaceutical preparations having  arcotic/psychotropic substances are under the purview of the Drugs and Cosmetic Act and the NDPS Act in India," it says.


http://www.deccanchronicle.com/technology/in-other-news/100716/internet-pharmacy-helping-unregulated-drug-sale-in-india.html

The All India Organisation of Chemists and Druggists in Courts





NEW DELHI: The fight between brick-and mortar chemists and online pharmacies is set to reach courts now. The All India Organisation of Chemists and Druggists (AIOCD) will approach ten High Courts in India against the central and state drug regulators for lack of action against the "illegal" operation of online pharmacies, which could compromise patient safety.

On their part, online pharmacies are gearing up for the fight in the hopes that it would clarify misconceptions about process they follow and also "expose" public safety hazards offline pharmacies pose.

The move comes even while a health ministry sub-committee is evaluating online pharmacies and their impact on health. Online pharmacies are illegal in India and the central and state drug regulators' negligence in this matter risks public health, AIOCD general secretary Suresh Gupta told ET.


http://timesofindia.indiatimes.com/tech/tech-news/Chemists-to-take-e-pharmacies-to-court/articleshow/53131252.cms

Sunday, July 10, 2016

Growing e-commerce in India helping easy availability of pharma drugs and abuse



Growing e-commerce in India is facilitating significant increase in online pharmacies, leading to easy availability of pharmaceutical drugs and their abuse, the Narcotics Control Bureau (NCB) says. In its annual report for 2015, published on Friday, the NCB says abuse of pharmaceutical drugs in India has assumed serious proportions in recent times and the problem seems to be more serious in the northeast and northwest region of the country.

"The emergence of illegal websites (Internet Pharmacy) established in the USA, Europe etc. offering unregulated trade in a range of prescription medicines over the Internet has taken firm root in India as a supplier. "These online pharmacies transmit orders from paying customers to agents in India, who then procure the medicines from either legitimate or illegitimate sources before dispatching them to customers by mail and courier," the NCB says.

The sheer volume of international post makes it impossible to screen every parcel and hence a vast majority of illegal consignments passes by undetected by the authorities."Internet pharmacies are usually highly vulnerable and keep the identity of organisers tightly veiled. In India, nevertheless, the NCB either on its own or in coordination with the outside agencies has been making at least one bust every year over the years," the report says. The pharmaceutical products that are abused include buprenorphine, codeine-based cough syrups, alprazolam, diazepam and other sedatives.

Many of these pharmaceutical drugs are easily available over the counter and this has become the major factor that encourages their misuse, the NCB says. There is also the perception that these pharmaceutical drugs are less harmful than hard drugs like heroin, cocaine etc. "However, this is a misconception, since these can be addictive and also have a debilitating effect on health.

Pharmaceutical preparations having narcotic/psychotropic substances are under the purview of the Drugs and Cosmetic Act and the NDPS Act in India," it says.

chemists and online e-pharmacies to reach courts








NEW DELHI: The fight between brick-and mortar chemists and online pharmacies is set to reach courts now. The All India Organisation of Chemists and Druggists (AIOCD) will approach ten High Courts in India against the central and state drug regulators for lack of action against the "illegal" operation of online pharmacies, which could compromise patient safety.

On their part, online pharmacies are gearing up for the fight in the hopes that it would clarify misconceptions about process they follow and also "expose" public safety hazards offline pharmacies pose.

The move comes even while a health ministry sub-committee is evaluating online pharmacies and their impact on health. Online pharmacies are illegal in India and the central and state drug regulators' negligence in this matter risks public health, AIOCD general secretary Suresh Gupta told ET.



The current Drugs & Cosmetics Act (1940) does not allow online portals to sell medicines, he said. "A major problem (with online pharmacies) is that the medicine could maybe change in transit.


It could be spurious and threaten the health of the (patient)," said Gupta. "It is surprising that the government is not taking action even when there is no law at present that allows online sale of medicines.


We are moving High Courts in at least 10 states." AIOCD's state-level units are in the process of preparing petitions against the government and will soon approach the High Courts in states like Delhi, Maharashtra, Uttar Pradesh, Tamil Nadu and Andhra Pradesh, said Gupta.

http://timesofindia.indiatimes.com/tech/tech-news/Chemists-to-take-e-pharmacies-to-court/articleshow/53131252.cms

Saturday, July 9, 2016

Pharma units face water, power supply problems:Pharmaceutical Manufacturers Association (GPMA)








Water, uninterrupted power supply and availability of skilled manpower are the major concerns affecting the working of pharmaceutical companies, highlighted the Goa Pharmaceutical Manufacturers Association (GPMA) recently.

The GPMA has asked to the government to take up the issues with various departments to help the industry. It also urged the EDC to come up with some incentives or schemes for upgradation of manufacturing units to meet ever growing requirements of regulatory guidelines.

The GPMA is also appealed to state FDA and the Central Drugs Standard Control Organisation (CDSCO), Goa to take up consultative meetings for updation of Drugs and Cosmetics Act 1945 to meet current scenario of export requirements.

The demands were made at the GPMA annual general meeting wherein Francis D’Souza, deputy chief minsiter was the chief guest. Speaking on the occasion D’Souza said that Goa’s pharmaceutical industry must take up upgradation of primary health centres as welll as discrict hospitals and Goa Medical College and Hospital (GMC). He said that there are several companies whose units are located in the state. “They must take up development of government health facilities through CSR programs,” said D’Souza.

D’Souza also urged industry to keep prices of essential medicines under control for patients. The government will provide the necessary infrastructure for smooth functioning of units, he assured industry.

Siddharth Kuncalienker, chairman, EDC was also one of the guests and in his address, he promised that the EDC would extend a helping hand to units for up gradation of their existing facilities.

Salim Veljee, director, FDA, in his address strongly recommended that CSR activities for health care centres need to be given top priority by industry for centres of health care. He pointed out that the process of simplifying  the Drugs and Cosmetic Act is ongoing and that lot of initiatives have been carried out on that front.

Earlier Suresh Kamath, outgoing president, GPMA, stressed the need of manufacturing units contributing atleast one per cent of their profitability the society.  There are over 70 units operating in Goa of which 40 units are 100% export oriented. The industry does over Rs 10,000 crore business annually which is almost 12 per cent of India’s exports in pharmaceuticals, said Kamath.

GPMA he said conducts various free medical camps across the state and gives scholarships to students of the Pharmacy College on merit and need basis. In addition it also conducts various technical seminars for pharma professionals working in various units in Goa, he said.

K Narendran, CDSO in his speech requested members to submit a copy of application for renewal of GMP to the local office for effective and faster clearance so that COPP ( certificate of pharmaceutical product) can issued by local FDA.

Sanjay Priolkar is the new GPMA president for a term of 2016-2018. Pant, treasurer GPMA proposed the vote of thanks.


http://www.navhindtimes.in/pharma-units-face-water-power-supply-problems-gpma/

Trans Pacific Partnership mega trade blocs are imperiling India’s role as pharmacy of the world



In a kind of pincer movement, two mega trade agreements from two ends of the world are closing in on India, forcing it to reconsider many of the policies that were formulated to protect its vulnerable economy and its even more vulnerable population.

On one side is the Trans Pacific Partnership, or TPP, which was signed in February. It is a behemoth, bringing together the US, Canada, Japan, Australia, New Zealand, Brunei, Chile, Malaysia, Mexico, Peru, Singapore and Vietnam – 12 nations that account for 40% of the world’s Gross Domestic Product and 26% of global trade. Many of these countries are amongst the most robust economies today.

On the other side is the Regional Comprehensive Economic Partnership, or RCEP, which has drawn the 10 members of the Association of Southeast Asian Nations (Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand and Vietnam) and six regional countries that have bilateral trade agreements with the bloc: Australia, China, India, Japan, New Zealand and South Korea.

The Regional Comprehensive Economic Partnership is still under negotiation and has just concluded its 13th round in Auckland. Together, these 16 countries – seven of whom are part of the Trans Pacific Partnership – have a combined GDP of $23 trillion (29% of world GDP) and account for 27% of global trade.

Shadow on Indian pharma

India is not a member of the Trans Pacific Partnership, yet its shadow looms over the country as it does over much of the world.

The agreement is setting new rules for trade, investment and standards across the board. From the public health point of view, it is considered the most lethal trade agreement signed so far and many of its provisions are being adopted by the Regional Comprehensive Economic Partnership too.

This is the single biggest worry for a host of organisations working in public health such as humanitarian organisation Médecins Sans Frontières, or MSF, which fears that India – as the world’s leading manufacturer of life-saving, low-cost generic medicines – is facing intense pressure in this proposed free trade agreement. “Many of the Intellectual Property provisions that have been tabled for RCEP are those in the TPP agreement, which is considered the worst trade deal ever for access to medicines,” said Brian Davies, East Asia head for MSF's Access Campaign.

The danger of secret negotiations

Utmost secrecy has marked both trade deals and the only way of knowing what is going on is through leaked documents. As the Auckland negotiations were underway, there was a barrage of statements and campaigns warning of what would happen if India were forced to accept the Intellectual Property draft text that is said to have been on the negotiating table.

This draft, finalised in October, was leaked by US-based non-profit Knowledge Ecology International, towards the end of April just as the 12th round of talks were starting in Perth.

Knowledge Ecology International is focused on social justice for the world’s most vulnerable populations, and is led by James Love who has been in the forefront of the campaign for access to cheaper medicines for two decades.

Releasing the draft, Love warned that the contents of the Intellectual Property chapter were important because it would bind India and China, two countries left out of the Trans Pacific Partnership, to strict new rules, particularly on pharmaceuticals.

China is the leading manufacturer of raw materials used to make medicines.

In a statement, the Knowledge Ecology International director said: “Japan and Korea are trying to push many of the worst ideas from ACTA [Anti-Counterfeiting Trade Agreement], TPP and other trade agreements into the RCEP. Some of the issues that negotiators did not understand in the TPP, such as the damages provisions, are also lurking in this text, creating risks that negotiators will do worse than they think, because the secrecy of the negotiations insulates the negotiators from timely feedback on technically complex issues.”

The Anti-Counterfeiting Trade Agreement has also been negotiated under a haze of secrecy by the US, Japan, the European Commission and other parties and is outside the ambit of the World Trade Organisation.

Japan and South Korea are reportedly pushing for patent extensions, restrictive rules on exceptions to copyright and test data monopolies. As Love pointed out, there are scores of proposals that circumscribe access to knowledge and will have a negative impact on the right to health. This is particularly worrying since Regional Comprehensive Economic Partnership countries are home to 48% of the world population, and among these are hugely impoverished and vulnerable communities.

The Intellectual Property rules put forward by Japan and South Korea go way beyond what is required under global trade rules embodied in the World Trade Organisation’s agreement that is known by its acronym TRIPS. As such, the stricter rules incorporated by rich countries in the newer trade agreements they have signed in recent years are called TRIPS plus provisions. India has consistently fought against these because they would choke its generics industry, which is the largest in the world.

End of cheap medicines?

India is described as the pharmacy of the developing world for its large-scale production of generic medicines that offer an affordable alternative to the high-cost patented drugs needed to treat communicable and non-communicable diseases in poorer countries. Two thirds of all the drugs that Médecins Sans Frontières buys to treat HIV, tuberculosis and malaria come from India.

If the current Intellectual Property provisions are accepted, access to essential medicines will be restricted for millions of people across Asia and Africa, points out Leena Menghaney, head of MSF's Access Campaign in South Asia.

What are the provisions causing so much apprehension?

Foremost is the provision to provide patent term extensions to compensate for delays in the marketing approval process. In effect, such a measure would extend the monopoly for patented medicines and delay entry of generics further.

So, too, the issue of data exclusivity. This is a mechanism to prevent governments from relying on the clinical trial data (provided by the patented drug manufacturer) to register generic versions of medicines – even if the medicines are off-patent, or even if the patent has been revoked. It is such a lethal provision that it even complicates the issuance of compulsory licences to override patents in case of a public health emergency. Data exclusivity is a prominent feature of the Trans Pacific Partnership and and it is not surprising that it is being sought to be incorporated in Regional Comprehensive Economic Partnership too.

Hobson's choice

The Union Ministry of Commerce has been getting uneasy over the implications of the Trans Pacific Partnership and, during the time of the previous United Progressive Alliance government, held a series of meetings to grapple with the issues that would keep Indian exports out of the largest trade bloc.

Some officials suggested that Indian industry should look at the Trans Pacific Partnership as an opportunity to raise its standards across the board to make exports more competitive. The bottom line is that the TPP rules will become the “gold standard” of global trade, making it a Hobson’s choice for India.

The Regional Comprehensive Economic Partnership is the focus of the ministry at present – it is primarily trying to ward off demands for a huge cut in import tariffs – the slew of heightened Intellectual Property protections being discussed should be causing acute unease.

The worst are weakened patentability criteria (making it easier for drug companies to patent their drugs) and diluted patent exceptions that would circumscribe how research and experimental exceptions to patent rights can be used by India.

Of concern too are what is known as border measures and enforcement. The former would result in the denial of medicines to patients in other developing countries since custom officials would be authorised to seize generic medicines that are being imported or exported, whereas enforcement measures could put third parties like treatment providers at risk of court cases and draw the pharmaceutical chain, from manufacturing, to distribution and retail of generics into litigation.

India's stand

The official Indian stand is that it will not accept TRIPS plus provisions. Health Minister JP Nadda had reaffirmed at the UN-High Level Meeting on Ending HIV/AIDS in early June that “India is committed to maintaining TRIPS flexibilities to ensure access to affordable medicines.”

However, there has been no specific statement with regard to RCEP negotiations. Nor has the usually forthright generics industry made any public comments on the Intellectual Property provisions in this agreement.

That could be on account of the altered situation in India. With an increasing number of companies entering into voluntary licences with patent holders, “the industry probably thinks it is politic not to rock the boat”, said an industry analyst.

Trade analysts believe India would be willing to make as many concessions as possible to join Regional Comprehensive Economic Partnership since it is left out of the Trans Pacific Partnership and other major groupings like the Asia-Pacific Economic Cooperation.

For Delhi, the RCEP allows it to reinforce its Look East policy that has not had much traction since it was initiated by Prime Minister PV Narasimha Rao in 1991. Even if the gains from the agreement are not all that significant – according to a study by the Asian Development Bank Institute, it will add just 2.4% to the GDP – it means India will be part of a powerful bloc.

http://scroll.in/pulse/811195/how-bangalore-scientists-are-slowly-cracking-one-of-the-toughest-cancer-mysteries-the-glioblastoma

Thursday, July 7, 2016

India Hyperlocal Market Outlook to 2020 - Driven by Surge in Number of Startups and Series of Funding Markets




Research and Markets has announced the addition of the "India Hyperlocal Market Outlook to 2020 - Driven by Surge in Number of Startups and Series of Funding" report to their offering.

The report titled "India Hyperlocal Market Outlook to 2020 - Driven by Surge in Number of Startups and Series of Funding" provides a comprehensive analysis of the various aspects such as market size of the India Hyperlocal Market, Logistics, Food, Groceries, Pharmacy, Horizontal and Concierge.

The report covers various aspects such as market size of India hyperlocal market, segmentation on the basis of regions, orders and revenue, by time of delivery, trends and developments, SWOT analysis, BCG Matrix, pre-requisites to enter the market and success and failure case studies of various Hyperlocal companies in the country.

The report also provides market share, business strategies, month-on-month order growth and key performance indicators of major companies in horizontal hyperlocal, food technology, grocery, pharmacy, concierge segment. The report also provides future analysis of overall hyperlocal market of India and its segments.

The report is useful for Hyperlocal vendors, investors and funding institutions, E-commerce companies and new players venturing in the market.

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. India Hyperlocal Market Introduction

4. India Hyperlocal Marketplace Market Size, 2014-2015

5. India Hyperlocal Marketplace Market Segmentation

6. Pre-Requisites to Enter into India Hyper local Market

7. How to Setup a Hyperlocal Marketplace in India

8. SWOT Analysis

9. Trends and Developments in India Hyperlocal Market

10. Issues and Challenges in India Hyperlocal Market

11. Boston Consultancy Group Matrix in India Hyperlocal Market

12. Competitive Landscape of Major Players in India Hyperlocal Market

13. India Hyperlocal Logistics Market

14. India Hyperlocal Grocery Market

15. India Hyperlocal Food Market

16. India Hyperlocal Pharmacy Market

17. India Horizontal Hyperlocal Market

18. Snapshot of India Hyperlocal Concierge Market

19. India Hyperlocal Market Future Outlook and Projections, 2016-2020

20. Possible Outcomes in India Hyperlocal Market in Future

21. Macro Economic Factors affecting India Hyperlocal Market

Companies Mentioned

- 1 mg

- Bhejjo

- Food Panda

- Foody's

- Get Now

- Go Zopping

- Grab.in

- Grofers

- Local Oye

- My Medisyn

- NinjaCart

- Opinio

- Oye-Waiter

- Pepper Tap

- PHLC

- Pluss

- Quickli

- Roadrunnr

- Scootsy

- Shadowfax

- Stockupp

- Tap Tap Meals

- Tiny Owl

- Urban Clap

- VDeliver

- Ziprun

For more information visit http://www.researchandmarkets.com/research/7h8mmn/india_hyperlocal

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716



SOURCE Research and Markets

http://www.prnewswire.com/news-releases/india-hyperlocal-market-outlook-to-2020---driven-by-surge-in-number-of-startups-and-series-of-funding---research-and-markets-300293318.html

The Indian pharmaceutical industry is growing in the tech pill for pharma sector



Institute watch

*   Institutes offering Pharmaceuticaltechnology are:

* Institute of Chemical Technology (ICT), Mumbai-

* Anna University , College of Engineering, Chennai

* Calcutta Institute of Pharmaceutical Technology, Kolkata

* Jadavpur University, Kolkata

Usha Albuquerque
Every day we hear about a new drug or medicine being developed. Today we have a drug for practically every disease, or are in the process of developing drugs to alleviate all diseases known to man. With the complexities of medicine and the thousands of drugs being developed and dispensed every day doctors and the general public have come to rely quite heavily on the specialised knowledge of pharmacists.

Pharmaceutical Engineering/Technology is a broad field connected to the process of designing, producing, and marketing pharmaceuticals. Pharmaceutical engineers are concerned with the transformation of raw materials into valuable products by chemical, biochemical or physical processes. Basically, this is a field of chemical engineering and pharmaceutical engineers utilise the concept of both biology and biochemistry to design, develop, and manufacture pharmaceutical drugs. They work alongside chemists and pharmacists to research and develop active pharmaceutical ingredients, and then formulate it into the product that a patient takes. Chemical and pharmaceutical engineering overlaps with other branches of engineering, as well as with chemistry and biochemistry. This blend of subject material and emphasis on a broad range of physical and chemical processes makes it a distinct and unique discipline. The other branches of Pharmaceutical Technology include: pharmaceutical formulation, pharmaceutical manufacturing, dispensing pharmacy, physical pharmacy and pharmaceutical jurisprudence.

Getting in
There are only a limited number of institutes that offer an undergraduate degree (BE/BTech/BSc) in pharmaceutical science and technology; so many youngsters enter the field at the moment with a chemical or industrial engineering degree.

The minimum eligibility for undergraduate programmes (BE/BTech/BSc) in pharmaceutical science and technology/ pharmaceutical engineering is Plus II with physics, chemistry, and mathematics as mandatory subjects. For admission to postgraduate programmes (ME/MTech/MSc), you would require a bachelor's degree in the relevant subject from a recognised university. Those interested can continue their studies after MTech in research work in the relevant field.

There are many different skills that a pharmaceutical engineer must possess, including a thorough understanding of the technical aspects of the work and of product development, manufacturing systems, quality control, compliance with regulations and production plants /equipment safety. You also need critical thinking and analytical skills, and an ability to design, maintain and operate highly specialised technology.

Job prospects
With more and more pharma companies taking to R&D there are ample growth opportunities for pharmaceutical engineers. They can work in manufacturing, as drug inspectors, drug analysts, pharmacology experts, production managers, and quality managers in government departments, research institutes and with pharmaceutical companies.

Most private pharmaceutical companies have their own research laboratories and recruit pharmaceutical technologists for carrying out research and development of drugs, and for conducting testing and clinical trials and quality control before the drugs are released in the market. These include companies like Dr. Reddy's Laboratories, Ranbaxy Laboratories, Cipla, Cadila Pharmaceuticals, Novartis India, Astra Zenecca and others. Food and drink companies and cosmetic manufacturing companies also employ pharmaceutical engineers to work in manufacturing, R & D and quality control.

There is also scope with government institutes and organisations involved in research and development of drugs and formulations, regulation of their quality, prices etc. These include institutes such as Central Drug Research Institute (CDRI) Lucknow; National Chemical Laboratory, Pune; Council of Scientific and Industrial Research (CSIR); Indian Institute of Chemical Technology, (IICT) Hyderabad; Central Drug Standards Control Organisation (CDSCO); National Pharma-Co-Vigilance Centre; The Department of Pharmacology, AIIMS, New Delhi; National Institute of Pharmaceutical Education and Research (NIPER); and Indian Medicines Pharmaceutical Corporation limited. (IMPCL).

Pharma engineers can also join Government as Drugs Inspectors in the area of regulatory affairs. This involves the licensing and inspection of medicines and their manufacture to ensure efficacy, safety and quality. Other opportunities for graduates in pharmaceutical sciences include teaching and academics.

The Indian pharmaceutical industry is growing in size and credibility. Not only do we export pharmaceuticals at cheaper prices to more than 200 countries, including USA, Russia, Germany, United Kingdom and Brazil, but India is also the leading supplier of AIDS drugs to the world. There is also a huge investment being made in setting up R & D laboratories for development of new drugs, for testing and contract research, all of which will require qualified pharmaceutical professionals.

So if you have the interest and the skills required for the career, there is scope for tremendous growth, both in the Indian market and globally.

http://www.tribuneindia.com/news/jobs-careers/be-the-tech-pill-for-pharma-sector/261568.html

Monday, July 4, 2016

After flooding destroyed a family's pharmacy





After flooding destroyed a family's pharmacy, costing them nearly $700,000 in medicine, Clendenin Pharmacy, Inc. is open once again.

Bill Ore's community pharmacy re-opened its doors today in an emergency capacity, offering service to anyone who needed it. After the devastating flooding last week, many residents are without the medicine they need.

"We're without a grocery store, a pharmacy, a barber shop, we have nothing," said Ore. "It's a catastrophe."

Ore credits his daughter, Lindsey, as the driving force behind the re-opening. According to Ore, she was the one who found and rented the lean-to trailer they could use as a part of the re-opening.

"I'm not sure I could've done it without [Lindsey]," Ore tells WSAZ. "I may have given up long ago."

The pharmacy officially opened today. While not yet at full service, the family expects to have their medicine shelves fully restocked by July 5th.

Ore and his daughter both say that because of the extensive damage done, the pharmacy will not only be servicing Clendenin, but also making deliveries to places like Clay and Elkview as well.

http://www.wsaz.com/content/news/Family-opens-pharmacy-in-spite-of-flood-damage-385320141.html

Life is all about motivation



Sindhu Joseph

CEO of CogniCor Technologies

Breaking the glass ceiling, this woman entrepreneur from Wayanad sheds light on her startup journey in a tete-a-tete with Pramod Thomas.  Her company’s Digital Assistant is now making waves in artificial intelligence and neuro-linguistic programming. But Sindhu Joseph says that the  other side of the startup journey has not been a bed of roses...

The entrepreneurial life of Sindhu Joseph, Co-founder and CEO of CogniCor Technologies, can be summed up with her journey from Wayanad to the US. Born to teachers in Wayanad, her success has seen her company collect several laurels, including the crown of the most innovative startup in Europe in 2012. Ask Joseph, and she describes her startup journey as “both sweet and bitter”

CogniCor, Joseph’s firm, offers advanced customer service technology. Its Digital Assistant has been pushing the boundaries of artificial intelligence and neuro-linguistic programming but Sindhu Joseph says that the journey has not been a bed of roses.

“Once I had to attend a few meetings in New York. I was thrilled when I found a single room for $18 per night with bare minimum facilities. The reception area was open and all kinds of people walked in and out. Towards evening, I began to feel itchy all over, but I ignored it. When I came back to the hotel, I could stand no longer, and as soon as I entered the reception, I removed my coat and there was not a single place in my body that was not bitten by bugs. When I showed this to the girl at the reception and she just handed me a $10 bill and asked me to buy a lotion from a nearby pharmacy. I spend the next night sitting on one stool. My husband has lived an entire month in our office because we thought we could save on rent,” she points out.

“I just wanted to highlight the other side of the startup journey. We lived a very precarious life,” she adds.

CogniCor got its first break in 2012, when it was selected as the top startup out of 350 startups for the accelerator program of Telefonica, one of the largest telecoms in Europe. Soon came the European award which eventually led to $1 million in seed funding in 2013. Now, the company has presences in three continents, Europe (Barcelona), Asia (India) and the US.

“The Indian startup life these days is glorified. Young college students listening to such hype think that it is the easiest and fastest way to make money. From our experience, it is a hard life. Only someone with motivation greater than making quick bucks or looking for a path to glory will persevere in such situations,” she signs off.

http://www.newindianexpress.com/business/news/Life-is-all-about-motivation-not-making-quick-bucks/2016/07/03/article3510859.ece

Saturday, July 2, 2016

Pharmaceuticals and retail to FDI serves one big purpose it prepares the country for attracting funds as global corporations











With green shoots in the economy looking to strike roots, the government’s decision on Monday to open up a buncWith green shoots in the economy looking to strike roots, the government’s decision on Monday to open up a bunch of sectors including defence, aviation, pharmaceuticals and retail to FDI serves one big purpose: it prepares the country for attracting funds as global corporations scout around for better returns with easy ownership rules in promising markets. Amidst global headwinds, India still is an economy with comparatively brighter growth prospects over the coming two years.h of sectors including defence, aviation, pharmaceuticals and retail to FDI serves one big purpose: it prepares the country for attracting funds as global corporations scout around for better returns with easy ownership rules in promising markets. Amidst global headwinds, India still is an economy with comparatively brighter growth prospects over the coming two years.

It was only last November that the government undertook an overhaul in the FDI regime targeting more than a dozen sectors including construction, airport services, banking, defence, broadcasting, etc. Monday’s measures are a continuation of the progressive liberalisation process. But the government could have dared to be even more radical given the fact that appetite for investment is low, and the scope for improvement both in terms of ‘ease of doing business’ and FDI rules in certain sectors leave many investors only half-convinced about the India story.

or instance, why cap foreign airline stake in Indian companies at 49 per cent when you do away with the FDI cap or in other words allow 100 per cent FDI? Foreign airlines, more than private equity funds or FIIs, would be interested in getting a larger share of the growing domestic business. Coupled with this, why shouldn’t the government put Air India on the disinvestment roster?

In some other sectors, say pharmaceuticals, the foreign investor concern is not so much FDI caps, but on the larger issue of price controls. While the government could have fully opened up the sector (it has now allowed up to 74 per cent FDI in brownfield projects under automatic approval), what’s bothering drug companies is the enlarging scope of drug price controls, which adversely affects profits. The sector can definitely do with more clarity and certainty on the pricing regime.

India did attract record FDI inflows of $55.46 billion in 2015-16 compared with $36.04 billion in the previous year. And FDI is far more durable and sustainable than foreign portfolio investments. FDI in manufacturing creates employment, quite desperately needed in a country like India where a million plus youth enter the job market every month.

http://indianexpress.com/article/explained/govts-100-fdi-window-of-opportunity-why-its-a-good-thing-but-could-have-been-even-better-2866628/